BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7027737)

  • 1. Effect of BCG vaccination on Mycobacterium lepraemurium infection in a highly susceptible inbred mouse strain.
    Løvik M; Closs O
    Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):133-8. PubMed ID: 7027737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of a sustained protection against murine leprosy in C3H mice vaccinated with extracts of Mycobacterium lepraemurium in admixture with Mycobacterium bovis (BCG).
    Turcotte R; Lemieux S
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):494-500. PubMed ID: 6763006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.
    Lefford MJ; Morgan R; Logie PS
    Infect Immun; 1980 Jun; 28(3):860-6. PubMed ID: 6995324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.
    Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1979 Dec; 38(3):461-74. PubMed ID: 394891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental murine leprosy: growth of Mycobacterium lepraemurium in C3H and C57/BL mice after footpad inoculation.
    Closs O
    Infect Immun; 1975 Sep; 12(3):480-9. PubMed ID: 1100521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1984 Jul; 57(1):115-22. PubMed ID: 6378458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro.
    Brett SJ; Butler R
    Immunology; 1986 Nov; 59(3):339-45. PubMed ID: 2431995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental murine leprosy. 6. Cellular reactions in the draining lymph node after injection of Mycobacterium lepraemurium into the foot-pads of mice.
    Haugen OA; Closs O
    Acta Pathol Microbiol Scand A; 1975 Nov; 83(6):683-92. PubMed ID: 1103567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice.
    Poulter LW; Lefford MJ
    Infect Immun; 1977 Aug; 17(2):439-46. PubMed ID: 330412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1983 Aug; 53(2):319-27. PubMed ID: 6349877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.
    Lefford MJ; Patel PJ; Poulter LW; Mackaness GB
    Infect Immun; 1977 Dec; 18(3):654-9. PubMed ID: 338487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory interactions between macrophages and T cells in Mycobacterium lepraemurium-specific T-cell activation.
    Brett SJ
    Cell Immunol; 1987 Dec; 110(2):379-90. PubMed ID: 3319191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.
    Roch F; Bach MA
    Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local reactivity, local resistance and systemic dissemination in Mycobacterium lepraemurium (MLM) infection.
    Løvik M; Closs O
    Clin Exp Immunol; 1989 Mar; 75(3):461-5. PubMed ID: 2649294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and treatment of anergy in murine leprosy.
    Juarez-Ortega M; Hernandez VG; Arce-Paredes P; Villanueva EB; Aguilar-Santelises M; Rojas-Espinosa O
    Int J Exp Pathol; 2015 Feb; 96(1):31-41. PubMed ID: 25529580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of route of Mycobacterium lepraemurium injection on susceptibility to mouse leprosy and on lymphoblastic transformation.
    Turcotte R
    Infect Immun; 1980 Jun; 28(3):660-8. PubMed ID: 6995320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity and delayed-type hypersensitivity in C57BL mice after immunization with live Mycobacterium lepraemurium and sonicated bacilli.
    Closs O; Løvik M
    Infect Immun; 1980 Jul; 29(1):17-23. PubMed ID: 6995335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically controlled phagocytic activity of macrophages and MHC-restricted T-cell proliferative response correlate with the resistance against MLM infection in mice.
    Saito N; Suzuki T; Natori T
    Exp Clin Immunogenet; 1987; 4(1):17-26. PubMed ID: 3078723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.